Search results for "Venous thromboembolism"
Iron/EPO combination beats other options for reducing transfusions
A review looked at trials comparing erythropoiesis-stimulating agents (EPO), iron, combination therapy with iron and EPO, hypoxia-inducible factor prolyl hydroxylase inhibitor, or vitamin D3 with controls on rates of red blood cell transfusion in the ICU.
https://acphospitalist.acponline.org/archives/2023/11/22/ironepo-combination-beats-other-options-for-reducing-icu-transfusions.htm
22 Nov 2023
New data on tocilizumab, convalescent plasma, anticoagulation for COVID-19
Recent studies found that tocilizumab was potentially harmful for ICU patients, indicated that convalescent plasma works better with higher antibody titers delivered earlier, and offered conflicting findings on anticoagulation. Other research compared mortality from COVID-19 over time.
https://acphospitalist.acponline.org/weekly/archives/2021/01/27/1.htm
27 Jan 2021
COPD meds, endocarditis, and more
Recent research from ACP Hospitalist Weekly.
https://acphospitalist.acponline.org/archives/2021/04/recent-research.htm
15 Apr 2021
Guidelines, studies make recommendations on VTE prophylaxis for inpatients with COVID-19
A new CHEST guideline supports standard-dose anticoagulant thromboprophylaxis, while authors of two recent studies of hypercoagulability called for higher doses.
https://acphospitalist.acponline.org/weekly/archives/2020/06/10/2.htm
10 Jun 2020
Sepsis cultures, resuscitation score, and more
Summaries from ACP Hospitalist Weekly.
https://acphospitalist.acponline.org/archives/2020/04/recent-research.htm
15 Apr 2020
December issue online and in the mail
The latest issue of ACP Hospitalist covers diabetes, gabapentinoids, high-value care, burnout, and antibiotic stewardship.
https://acphospitalist.acponline.org/weekly/archives/2019/12/11/5.htm
11 Dec 2019
Venous thromboembolism in malignancy
Patients with a VTE have more than a fourfold increased risk for cancer compared with the general population. In patients with a known malignancy, the annual incidence of VTE is 1 in 200.
https://acphospitalist.acponline.org/archives/2017/03/expert-analysis-vte-malignancy.htm
15 Mar 2017
Hospitals' volume of PE treatment associated with 30-day PE-related mortality
Patients treated for pulmonary embolism (PE) at hospitals that saw at least 40 PEs per year had about half the rate of mortality from PE as patients treated at hospitals that saw fewer than 15 PEs per year.
https://acphospitalist.acponline.org/weekly/archives/2019/08/07/2.htm
7 Aug 2019
An agenda for hospitalists' research
The pandemic added opportunities and barriers to an already challenged field.
https://acphospitalist.acponline.org/archives/2021/05/an-agenda-for-hospitalists-research.htm
15 May 2021
Latest research looks at clots, drug therapies, and pneumonia guidance
Studies offered further support for anticoagulation in patients with COVID-19 but showed no benefit from hydroxychloroquine or lopinavir-ritonavir. The authors of recent pneumonia guidelines explained how the recommendations apply to COVID-19 patients.
https://acphospitalist.acponline.org/weekly/archives/2020/05/13/2.htm
13 May 2020